CryoPort (NASDAQ:CYRX) Sets New 52-Week High – Here’s What Happened

CryoPort, Inc. (NASDAQ:CYRX)’s stock price hit a new 52-week high during mid-day trading on Thursday . The company traded as high as $11.45 and last traded at $11.2870, with a volume of 92876 shares. The stock had previously closed at $10.98.

Analysts Set New Price Targets

CYRX has been the topic of a number of recent research reports. UBS Group lifted their price target on shares of CryoPort from $11.00 to $12.50 and gave the company a “buy” rating in a research report on Wednesday, November 5th. Weiss Ratings restated a “sell (d+)” rating on shares of CryoPort in a report on Monday, December 29th. Finally, Needham & Company LLC increased their price target on CryoPort from $11.00 to $12.00 and gave the company a “buy” rating in a report on Wednesday, November 5th. Eight research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $12.83.

CryoPort Stock Down 4.9%

The firm’s 50 day moving average price is $9.80 and its two-hundred day moving average price is $9.18. The firm has a market capitalization of $520.22 million, a PE ratio of 8.88 and a beta of 1.54. The company has a quick ratio of 15.01, a current ratio of 15.77 and a debt-to-equity ratio of 0.40.

CryoPort (NASDAQ:CYRX) last issued its quarterly earnings data on Tuesday, November 4th. The company reported ($0.18) EPS for the quarter, topping analysts’ consensus estimates of ($0.23) by $0.05. The firm had revenue of $44.23 million for the quarter, compared to analyst estimates of $41.22 million. CryoPort had a net margin of 35.57% and a negative return on equity of 11.07%. As a group, research analysts forecast that CryoPort, Inc. will post -0.99 EPS for the current fiscal year.

Insider Transactions at CryoPort

In other CryoPort news, Director Ramkumar Mandalam sold 11,570 shares of the company’s stock in a transaction that occurred on Wednesday, December 10th. The stock was sold at an average price of $9.99, for a total value of $115,584.30. Following the transaction, the director directly owned 80,758 shares of the company’s stock, valued at $806,772.42. This represents a 12.53% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 10.00% of the stock is owned by corporate insiders.

Institutional Trading of CryoPort

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Nisa Investment Advisors LLC boosted its stake in CryoPort by 299.9% during the 2nd quarter. Nisa Investment Advisors LLC now owns 3,639 shares of the company’s stock valued at $27,000 after acquiring an additional 2,729 shares during the last quarter. Tower Research Capital LLC TRC raised its stake in shares of CryoPort by 300.1% in the 2nd quarter. Tower Research Capital LLC TRC now owns 5,833 shares of the company’s stock valued at $44,000 after purchasing an additional 4,375 shares in the last quarter. Whittier Trust Co. of Nevada Inc. bought a new position in shares of CryoPort during the third quarter worth about $53,000. ProShare Advisors LLC acquired a new position in CryoPort in the second quarter worth about $75,000. Finally, AlphaQuest LLC bought a new stake in CryoPort in the third quarter valued at about $79,000. Institutional investors own 92.90% of the company’s stock.

About CryoPort

CryoPort, Inc (NASDAQ: CYRX) is a global provider of temperature-controlled logistics solutions for the life sciences industry. The company specializes in cryogenic shipping for critical biological materials, supporting the development, clinical testing and commercialization of cell and gene therapies, biologics, vaccines and reproductive medicine. By offering end-to-end supply chain management, CryoPort helps ensure the integrity and viability of temperature-sensitive products from point of origin to destination.

CryoPort’s product portfolio includes proprietary cryogenic dry shippers, advanced active and passive thermal packaging, and real-time data monitoring platforms.